Recent News

• 12.03.2025 - Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
• 11.12.2025 - Pulmonx Reports Third Quarter 2025 Financial Results
• 10.27.2025 - Pulmonx Announces Management Transition and Preliminary Third Quarter 2025 Revenue; Reschedules Third Quarter 2025 Earnings Call to November 12, 2025
• 10.15.2025 - Pulmonx to Report Third Quarter 2025 Financial Results on October 29, 2025
• 09.11.2025 - Lake Street Best Ideas Growth (BIG9) Conference
• 09.11.2025 - Lake Street Best Ideas Growth (BIG9) Conference
• 09.04.2025 - Wells Fargo Healthcare Conference

Recent Filings

• 11.25.2025 - EFFECT Notice of Effectiveness
• 11.24.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 11.24.2025 - S-3/A Registration statement under Securities Act of 1933
• 11.13.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.12.2025 - 8-K Current report
• 11.12.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.12.2025 - EX-99.1 EX-99.1
• 11.10.2025 - 3 Initial statement of beneficial ownership of securities
• 11.07.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 10.27.2025 - 8-K Current report